These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 22585603)

  • 21. Clinicopathologic and molecular significance of phospho-Akt expression in early invasive breast cancer.
    Aleskandarany MA; Rakha EA; Ahmed MA; Powe DG; Ellis IO; Green AR
    Breast Cancer Res Treat; 2011 Jun; 127(2):407-16. PubMed ID: 20617378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intermedin: a novel regulator for vascular remodeling and tumor vessel normalization by regulating vascular endothelial-cadherin and extracellular signal-regulated kinase.
    Zhang W; Wang LJ; Xiao F; Wei Y; Ke W; Xin HB
    Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2721-32. PubMed ID: 22922959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting AKT signaling sensitizes cancer to cellular immunotherapy.
    Hähnel PS; Thaler S; Antunes E; Huber C; Theobald M; Schuler M
    Cancer Res; 2008 May; 68(10):3899-906. PubMed ID: 18483275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New pathways and mechanisms regulating and responding to Delta-like ligand 4-Notch signalling in tumour angiogenesis.
    Oon CE; Harris AL
    Biochem Soc Trans; 2011 Dec; 39(6):1612-8. PubMed ID: 22103496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Semaphorin SEMA3F affects multiple signaling pathways in lung cancer cells.
    Potiron VA; Sharma G; Nasarre P; Clarhaut JA; Augustin HG; Gemmill RM; Roche J; Drabkin HA
    Cancer Res; 2007 Sep; 67(18):8708-15. PubMed ID: 17875711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of RAF/MEK/ERK and PI3K/AKT/mTOR pathways in pituitary adenomas and their effects on downstream effectors.
    Dworakowska D; Wlodek E; Leontiou CA; Igreja S; Cakir M; Teng M; Prodromou N; Góth MI; Grozinsky-Glasberg S; Gueorguiev M; Kola B; Korbonits M; Grossman AB
    Endocr Relat Cancer; 2009 Dec; 16(4):1329-38. PubMed ID: 19620247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diaminothiazoles inhibit angiogenesis efficiently by suppressing Akt phosphorylation.
    Thomas SA; Thamkachy R; Ashokan B; Komalam RJ; Sreerekha KV; Bharathan A; Santhoshkumar TR; Rajasekharan KN; Sengupta S
    J Pharmacol Exp Ther; 2012 Jun; 341(3):718-24. PubMed ID: 22414853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Laminin alpha2 chain (merosin M chain) distribution and VEGF, FGF(2), and TGFbeta1 gene expression in angiogenesis of supraglottic, lung, and breast carcinomas.
    Vitolo D; Ciocci L; Cicerone E; Rossi C; Tiboni F; Ferrauti P; Gallo A; Baroni CD
    J Pathol; 2001 Sep; 195(2):197-208. PubMed ID: 11592099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coexistence of the loss of heterozygosity at the PTEN locus and HER2 overexpression enhances the Akt activity thus leading to a negative progesterone receptor expression in breast carcinoma.
    Tokunaga E; Oki E; Kimura Y; Yamanaka T; Egashira A; Nishida K; Koga T; Morita M; Kakeji Y; Maehara Y
    Breast Cancer Res Treat; 2007 Mar; 101(3):249-57. PubMed ID: 17006756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Magnolol down-regulates HER2 gene expression, leading to inhibition of HER2-mediated metastatic potential in ovarian cancer cells.
    Chuang TC; Hsu SC; Cheng YT; Shao WS; Wu K; Fang GS; Ou CC; Wang V
    Cancer Lett; 2011 Dec; 311(1):11-9. PubMed ID: 21757288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PI3 kinase integrates Akt and MAP kinase signaling pathways in the regulation of prostate cancer.
    Goc A; Al-Husein B; Kochuparambil ST; Liu J; Heston WW; Somanath PR
    Int J Oncol; 2011 Jan; 38(1):267-77. PubMed ID: 21109949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clear cell sarcoma of the kidney: up-regulation of neural markers with activation of the sonic hedgehog and Akt pathways.
    Cutcliffe C; Kersey D; Huang CC; Zeng Y; Walterhouse D; Perlman EJ;
    Clin Cancer Res; 2005 Nov; 11(22):7986-94. PubMed ID: 16299227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Akt DUBbed InAktive.
    Lin K
    Sci Signal; 2013 Jan; 6(257):pe1. PubMed ID: 23300338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Muon disrupts AKT hydrogen bond network in cancer.
    Radisavljevic Z
    J Cell Physiol; 2019 Jun; 234(6):7994-7998. PubMed ID: 30317599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lysosome AKT Targeting in Metastatic Cancer.
    Radisavljevic Z
    Crit Rev Eukaryot Gene Expr; 2020; 30(2):121-123. PubMed ID: 32558491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Laser Disrupts AKT Hydrogen Network in Cancer.
    Radisavljevic Z
    Crit Rev Eukaryot Gene Expr; 2020; 30(4):369-375. PubMed ID: 32894666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Switching Akt: from survival signaling to deadly response.
    Los M; Maddika S; Erb B; Schulze-Osthoff K
    Bioessays; 2009 May; 31(5):492-5. PubMed ID: 19319914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lysosome activates AKT inducing cancer and metastasis.
    Radisavljevic Z
    J Cell Biochem; 2019 Aug; 120(8):12123-12127. PubMed ID: 31021471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Achieving specificity in Akt signaling in cancer.
    Toker A
    Adv Biol Regul; 2012 Jan; 52(1):78-87. PubMed ID: 21986444
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.